| Patents for A61K 38 - Medicinal preparations containing peptides (316,240) |
|---|
| 06/07/1988 | US4749689 Hemostatic agent composed of collagen/gelatin and protamine |
| 06/07/1988 | US4749688 Use of neutral metalloendopeptidase inhibitors in the treatment of hypertension |
| 06/07/1988 | US4749687 Renin inhibitors containing statine or derivatives thereof |
| 06/07/1988 | US4749686 Combinations of renal vasodilators and α1 -adrenergic or ganglionic blocking agents and methods for treating diseases |
| 06/07/1988 | US4749685 Immunosuppressive peptides |
| 06/07/1988 | US4749684 Method for increasing hair growth |
| 06/07/1988 | US4749683 Inhibition of gastric acid secretion with alpha-transforming growth factor |
| 06/07/1988 | US4749571 Physiologically-active novel substance "Aldostatin" and production method thereof |
| 06/07/1988 | US4749570 Targeting conjugates of albumin and therapeutic agents |
| 06/07/1988 | US4749522 Lipids, proteins, polysaccharides, and nucleotides from tissue; purification or separation with gases |
| 06/07/1988 | CA1237713A1 Peptides having an immunostimulating action, processes for their preparation and their use |
| 06/07/1988 | CA1237669A1 Method for purifying gamma-interferon |
| 06/02/1988 | WO1988003954A1 Method of isolating ca 125 antigen |
| 06/02/1988 | WO1988003951A1 Recombinant alzheimer's amyloid protein |
| 06/02/1988 | WO1988003949A1 The cs protein of the corpuscles of stannius |
| 06/02/1988 | WO1988003928A1 Method for inducing vaginal lubrication |
| 06/02/1988 | WO1988003810A1 Pharmaceutically active conjugates having improved body tissue binding specificity |
| 06/02/1988 | WO1988003809A1 Means for protecting against bordetella infections and toxic processes |
| 06/02/1988 | WO1988003808A1 Method for treating iron overload |
| 06/02/1988 | WO1988003807A2 Production and use of a novel t-cell suppressor factor |
| 06/01/1988 | EP0269595A2 Agent for the regulation of the appetite or a sleeping agent |
| 06/01/1988 | EP0269520A2 Retrovirus of the type HIV-2, susceptible to provoke AIDS, and its antigenic and nucleic-acid constituents |
| 06/01/1988 | EP0269408A2 TGF-Beta in the treatment of inflammatory disorders |
| 06/01/1988 | EP0269405A2 Pasteurization of immunoglobulin solutions |
| 06/01/1988 | EP0269394A2 Method for treating iron overload |
| 06/01/1988 | EP0269389A2 Peptides |
| 06/01/1988 | EP0269322A1 Virginiamycin analogs |
| 06/01/1988 | EP0269311A2 Methods of treating bone diseases by administration of a cysteine proteinase inhibitor |
| 06/01/1988 | EP0269299A2 Atrial peptides |
| 06/01/1988 | EP0269220A2 Derivatives of alpha-hANP and their production |
| 06/01/1988 | EP0269188A2 Cytotoxic conjugates useful in therapy, and process for obtaining them |
| 06/01/1988 | EP0269017A2 Therapeutic combination of free-radical scavenger or metabolic inhibitor and biologically active protein |
| 06/01/1988 | EP0268973A2 Process for manufacturing a virus-free, stable and intravenously tolerant immunoglobulin-G preparation |
| 06/01/1988 | EP0268946A2 Method for separating long-chain nucleic acids |
| 06/01/1988 | EP0268868A2 Pharmaceutical compositions for the treatment of gastro-intestinal diseases |
| 06/01/1988 | EP0268772A2 Expression of biologically active factor XIII |
| 06/01/1988 | EP0268678A1 Novel 5-fluorouridine compounds and process for their preparation |
| 06/01/1988 | EP0268663A1 Phosphopeptides. |
| 06/01/1988 | EP0268636A1 Fc receptor for immunoglobulin. |
| 06/01/1988 | EP0113749B1 A process of preparing a crystallised carbohydrate matrix for biologically active substances |
| 05/31/1988 | US4748232 Peptide production and use thereof |
| 05/31/1988 | US4748160 Angiotensin converting enzyme inhibitors and their formulation and use as pharmaceuticals |
| 05/31/1988 | US4748157 Composition for gastrointestinal ulcers |
| 05/31/1988 | US4748156 Thrombin-binding substance and process for preparing the same |
| 05/31/1988 | US4748155 Pharmacologically active tripeptides and process for their synthesis |
| 05/31/1988 | US4748154 Peptide derivatives, their production and use |
| 05/31/1988 | US4748153 Compounds having somatostatin-like activity useful as local anti-inflammatory agents |
| 05/31/1988 | US4748112 Methods and compositions relating to regression-associated antigens |
| 05/31/1988 | US4748018 Method of passive immunization of mammals using avian antibody |
| 05/31/1988 | US4747825 Administration of dynamic dosage interrupted by periods of non administration |
| 05/25/1988 | EP0268561A2 Production and use of a novel T-cell suppressor factor |
| 05/25/1988 | EP0268501A1 Proteins having a glutathion-S-transferase activity, DNA sequences, antibodies, pox viruses and medicaments for the prevention of schistosomiasis |
| 05/25/1988 | EP0268468A2 Antibodies |
| 05/25/1988 | EP0268446A2 An antiidiotypic T-cell hybridoma |
| 05/25/1988 | EP0268377A2 Glutamic acid derivatives, processes and intermediates for their preparation and pharmaceutical formulations containing them |
| 05/25/1988 | EP0268297A2 Peptides with sulfate ester groups |
| 05/25/1988 | EP0268279A2 Hybridomas producing monoclonal antibodies to new mucin epitopes |
| 05/25/1988 | EP0268243A2 Packing material and process for its production |
| 05/25/1988 | EP0268110A1 Pharmaceutical compositions of recombinant interleukin-2 and formulation processes |
| 05/25/1988 | EP0268066A2 Fertility control and uterine therapy in dogs with luteinizing hormone releasing hormone antagonists |
| 05/25/1988 | EP0267998A1 Means for protecting against bordetella infections and toxic processes |
| 05/24/1988 | US4746731 Diagnose diseases of human organs |
| 05/24/1988 | US4746730 Bio-available iron-protein derivatives and process for their preparation |
| 05/24/1988 | US4746729 Cartilage-derived leukocyte elastase-inhibitor |
| 05/24/1988 | US4746728 8-glycine, des-19-leucine-calcitonin |
| 05/24/1988 | US4746676 Carboxyalkyl dipeptide compounds |
| 05/24/1988 | US4746675 Enhanced penetration of drug through skin or mucosa |
| 05/24/1988 | US4746508 Drug administration |
| 05/19/1988 | WO1988003566A1 Antibodies |
| 05/19/1988 | WO1988003565A1 Antibodies |
| 05/19/1988 | WO1988003559A1 Recombinant hybrid immunoglobulin molecules and method of use |
| 05/19/1988 | WO1988003537A1 Novel peptides |
| 05/19/1988 | WO1988003536A1 Pancreastatin |
| 05/19/1988 | WO1988003535A1 Peptide compounds |
| 05/19/1988 | WO1988003412A1 Solubilization of proteins for pharmaceutical compositions using polyproline conjugation |
| 05/19/1988 | WO1988003411A1 Improved interferon therapy |
| 05/19/1988 | WO1988003410A1 Viral agent for nanb hepatitis, antigen and immunologic reagent |
| 05/19/1988 | WO1988003409A1 Wound healing and bone regeneration |
| 05/19/1988 | WO1988003408A1 Extra pure semi-synthetic blood substitute |
| 05/19/1988 | WO1988000833A3 Antipyretic and anti-inflammatory peptides |
| 05/18/1988 | EP0267802A2 Synthetic antigen for the detection of aids-related disease |
| 05/18/1988 | EP0267781A2 Method for selecting hybridomas producing antibodies specific to the P-glycoprotein cell surface antigen and a CDNA clone encoding the C-term |
| 05/18/1988 | EP0267779A2 Human pleiotropic immune factor and muteins thereof |
| 05/18/1988 | EP0267741A1 Peptide compounds |
| 05/18/1988 | EP0267703A1 Human apolipoprotein AI and variant form of the same expressed in Escherichia coli |
| 05/18/1988 | EP0267684A2 Human leukocyte interferon composition and skin treatment |
| 05/18/1988 | EP0267678A1 Recombinant human erythropoietin |
| 05/18/1988 | EP0267629A2 Polypeptides having interleukin-1 activity |
| 05/18/1988 | EP0267615A2 Compositions and method for treatment of cancer using monoclonal antibody against GD3 ganglioside together with IL-2 |
| 05/18/1988 | EP0267463A2 Tissue-derived tumor growth inhibitors, methods of preparation and uses thereof |
| 05/18/1988 | EP0267402A2 Use of follicle regulatory protein for the production of a therapeutic agent for the treatment of neoplasm of gonadal origin |
| 05/18/1988 | EP0267275A1 A DNA SEQUENCE ENCODING THE $i(ROS) ONCOGENE, POLYPEPTIDES ENCODED THEREFROM, AND DIAGNOSTIC AND OTHER METHODS BASED THEREON |
| 05/18/1988 | EP0267272A1 Atrial natriuretic peptide receptor protein and its encoding dna |
| 05/18/1988 | EP0267208A1 An insulin preparation for non-parenteral administration. |
| 05/18/1988 | CN87106235A Method and substrate composition for treating atheroscterosis |
| 05/18/1988 | CN87103560A Pharmaceutical compositions |
| 05/17/1988 | US4745180 Solubilization of proteins for pharmaceutical compositions using heparin fragments |
| 05/17/1988 | US4745177 Anticoagulants, polypeptides |
| 05/17/1988 | US4745124 Orally effective anti-hypertensive agents |
| 05/17/1988 | US4745102 Novel treatment method |